Clinical Trial Detail

NCT ID NCT01501487
Title MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I
Recruitment Completed
Gender female
Phase FDA approved
Variant Requirements No
Sponsors Agendia
Indications

breast cancer

Therapies

Cyclophosphamide + Docetaxel + Doxorubicin

Cyclophosphamide + Epirubicin + Fluorouracil

Paclitaxel

Pegfilgrastim

Cyclophosphamide + Docetaxel

Cyclophosphamide + Doxorubicin

Carboplatin + Docetaxel + Trastuzumab

Docetaxel + Pertuzumab + Trastuzumab

Age Groups: adult

No variant requirements are available.